A portion of nasopharyngeal carcinoma patients can meet the criteria for clinical cure. It largely depends on the specific staging and type of the cancer. Patients with higher differentiation and earlier stages, especially stages one and two, tend to have better treatment outcomes. Currently, radiation therapy is the primary treatment, and some patients may also need to undergo chemotherapy. Overall, chemotherapy is quite effective for most patients. However, whether clinical cure can be achieved primarily depends on the extent of the disease and individual differences. Some people respond better to radiotherapy and chemotherapy, which in turn increases their chances of clinical cure. The five-year survival rate is considered the most important indicator.